Product Code: TMRGL69005
Custom Antibody Market - Scope of Report:
TMR's report on the global custom antibody market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global custom antibody market for the period 2017-2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global custom antibody market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the custom antibody market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global custom antibody market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global custom antibody market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global custom antibody market.
The report delves into the competitive landscape of the global custom antibody market. Key players operating in the global custom antibody market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global custom antibody market profiled in this report.
Key Questions Answered in Global Custom Antibody Market Report:
- What is the sales/revenue generated by custom antibody across all regions during the forecast period?
- What are the opportunities in the global custom antibody market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2033?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Custom Antibody Market - Research Objectives and Research Approach:
The comprehensive report on the global custom antibody market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global custom antibody market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global custom antibody market.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter's Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
4. Global Custom Antibody Market Analysis 2018-2022 and Forecast, 2023-2033
- 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
- 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
5. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Service
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Million) Analysis By Service, 2018-2022
- 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service, 2023-2033
- 5.3.1. Antibody Development
- 5.3.2. Antibody Production & Purification
- 5.3.3. Antibody Fragmentation & Labeling
- 5.4. Y-o-Y Growth Trend Analysis By Service, 2018-2022
- 5.5. Absolute $ Opportunity Analysis By Service, 2023-2033
6. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Type
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022
- 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033
- 6.3.1. Monoclonal Antibodies
- 6.3.2. Polyclonal Antibodies
- 6.3.3. Recombinant Antibodies
- 6.3.4. Other Custom Antibodies
- 6.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022
- 6.5. Absolute $ Opportunity Analysis By Type, 2023-2033
7. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Source
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Million) Analysis By Source , 2018-2022
- 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source , 2023-2033
- 7.3.1. Mice
- 7.3.2. Rabbits
- 7.3.3. Other Sources
- 7.4. Y-o-Y Growth Trend Analysis By Source , 2018-2022
- 7.5. Absolute $ Opportunity Analysis By Source , 2023-2033
8. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Research Area
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size Value (US$ Million) Analysis By Research Area, 2018-2022
- 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Research Area, 2023-2033
- 8.3.1. Oncology
- 8.3.2. Infectious Diseases
- 8.3.3. Neurobiology
- 8.3.4. Stem Cells
- 8.3.5. Immunology
- 8.3.6. Cardiovascular Disease
- 8.3.7. Other Research Areas
- 8.4. Y-o-Y Growth Trend Analysis By Research Area, 2018-2022
- 8.5. Absolute $ Opportunity Analysis By Research Area, 2023-2033
9. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By End User
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
- 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
- 9.3.1. Pharmaceutical & Biotechnology Companies
- 9.3.2. Academic & Research Institutes
- 9.3.3. Contract Research Organizations
- 9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
- 9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Region
- 10.1. Introduction
- 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
- 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia Pacific
- 10.3.5. Middle East and Africa
- 10.4. Market Attractiveness Analysis By Region
11. North America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
- 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
- 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
- 11.2.1. By Country
- 11.2.1.1. U.S.
- 11.2.1.2. Canada
- 11.2.2. By Service
- 11.2.3. By Type
- 11.2.4. By Source
- 11.2.5. By Research Area
- 11.2.6. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Service
- 11.3.3. By Type
- 11.3.4. By Source
- 11.3.5. By Research Area
- 11.3.6. By End User
- 11.4. Key Takeaways
12. Latin America Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
- 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
- 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
- 12.2.1. By Country
- 12.2.1.1. Brazil
- 12.2.1.2. Mexico
- 12.2.1.3. Rest of Latin America
- 12.2.2. By Service
- 12.2.3. By Type
- 12.2.4. By Source
- 12.2.5. By Research Area
- 12.2.6. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Service
- 12.3.3. By Type
- 12.3.4. By Source
- 12.3.5. By Research Area
- 12.3.6. By End User
- 12.4. Key Takeaways
13. Europe Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
- 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
- 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
- 13.2.1. By Country
- 13.2.1.1. U.K.
- 13.2.1.2. Spain
- 13.2.1.3. Germany
- 13.2.1.4. Italy
- 13.2.1.5. France
- 13.2.1.6. Rest of Europe
- 13.2.2. By Service
- 13.2.3. By Type
- 13.2.4. By Source
- 13.2.5. By Research Area
- 13.2.6. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Service
- 13.3.3. By Type
- 13.3.4. By Source
- 13.3.5. By Research Area
- 13.3.6. By End User
- 13.4. Key Takeaways
14. Asia Pacific Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
- 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
- 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
- 14.2.1. By Country
- 14.2.1.1. China
- 14.2.1.2. Japan
- 14.2.1.3. India
- 14.2.1.4. Rest of Asia Pacific
- 14.2.2. By Service
- 14.2.3. By Type
- 14.2.4. By Source
- 14.2.5. By Research Area
- 14.2.6. By End User
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Service
- 14.3.3. By Type
- 14.3.4. By Source
- 14.3.5. By Research Area
- 14.3.6. By End User
- 14.4. Key Takeaways
15. Middle East and Africa Custom Antibody Market Analysis 2018-2022 and Forecast 2023-2033, By Country
- 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
- 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
- 15.2.1. By Country
- 15.2.1.1. South Africa
- 15.2.1.2. GCC Countries
- 15.2.1.3. Rest of Middle East and Africa
- 15.2.2. By Service
- 15.2.3. By Type
- 15.2.4. By Source
- 15.2.5. By Research Area
- 15.2.6. By End User
- 15.3. Market Attractiveness Analysis
- 15.3.1. By Country
- 15.3.2. By Service
- 15.3.3. By Type
- 15.3.4. By Source
- 15.3.5. By Research Area
- 15.3.6. By End User
- 15.4. Key Takeaways
16. Key Countries Custom Antibody Market Analysis
- 16.1. U.S.
- 16.1.1. Pricing Analysis
- 16.1.2. Market Share Analysis, 2022
- 16.1.2.1. By Service
- 16.1.2.2. By Type
- 16.1.2.3. By Source
- 16.1.2.4. By Research Area
- 16.1.2.5. By End User
- 16.2. Canada
- 16.2.1. Pricing Analysis
- 16.2.2. Market Share Analysis, 2022
- 16.2.2.1. By Service
- 16.2.2.2. By Type
- 16.2.2.3. By Source
- 16.2.2.4. By Research Area
- 16.2.2.5. By End User
- 16.3. Brazil
- 16.3.1. Pricing Analysis
- 16.3.2. Market Share Analysis, 2022
- 16.3.2.1. By Service
- 16.3.2.2. By Type
- 16.3.2.3. By Source
- 16.3.2.4. By Research Area
- 16.3.2.5. By End User
- 16.4. Mexico
- 16.4.1. Pricing Analysis
- 16.4.2. Market Share Analysis, 2022
- 16.4.2.1. By Service
- 16.4.2.2. By Type
- 16.4.2.3. By Source
- 16.4.2.4. By Research Area
- 16.4.2.5. By End User
- 16.5. U.K.
- 16.5.1. Pricing Analysis
- 16.5.2. Market Share Analysis, 2022
- 16.5.2.1. By Service
- 16.5.2.2. By Type
- 16.5.2.3. By Source
- 16.5.2.4. By Research Area
- 16.5.2.5. By End User
- 16.6. Spain
- 16.6.1. Pricing Analysis
- 16.6.2. Market Share Analysis, 2022
- 16.6.2.1. By Service
- 16.6.2.2. By Type
- 16.6.2.3. By Source
- 16.6.2.4. By Research Area
- 16.6.2.5. By End User
- 16.7. Germany
- 16.7.1. Pricing Analysis
- 16.7.2. Market Share Analysis, 2022
- 16.7.2.1. By Service
- 16.7.2.2. By Type
- 16.7.2.3. By Source
- 16.7.2.4. By Research Area
- 16.7.2.5. By End User
- 16.8. Italy
- 16.8.1. Pricing Analysis
- 16.8.2. Market Share Analysis, 2022
- 16.8.2.1. By Service
- 16.8.2.2. By Type
- 16.8.2.3. By Source
- 16.8.2.4. By Research Area
- 16.8.2.5. By End User
- 16.9. France
- 16.9.1. Pricing Analysis
- 16.9.2. Market Share Analysis, 2022
- 16.9.2.1. By Service
- 16.9.2.2. By Type
- 16.9.2.3. By Source
- 16.9.2.4. By Research Area
- 16.9.2.5. By End User
- 16.10. China
- 16.10.1. Pricing Analysis
- 16.10.2. Market Share Analysis, 2022
- 16.10.2.1. By Service
- 16.10.2.2. By Type
- 16.10.2.3. By Source
- 16.10.2.4. By Research Area
- 16.10.2.5. By End User
- 16.11. Japan
- 16.11.1. Pricing Analysis
- 16.11.2. Market Share Analysis, 2022
- 16.11.2.1. By Service
- 16.11.2.2. By Type
- 16.11.2.3. By Source
- 16.11.2.4. By Research Area
- 16.11.2.5. By End User
- 16.12. India
- 16.12.1. Pricing Analysis
- 16.12.2. Market Share Analysis, 2022
- 16.12.2.1. By Service
- 16.12.2.2. By Type
- 16.12.2.3. By Source
- 16.12.2.4. By Research Area
- 16.12.2.5. By End User
- 16.13. South Africa
- 16.13.1. Pricing Analysis
- 16.13.2. Market Share Analysis, 2022
- 16.13.2.1. By Service
- 16.13.2.2. By Type
- 16.13.2.3. By Source
- 16.13.2.4. By Research Area
- 16.13.2.5. By End User
- 16.14. GCC Countries
- 16.14.1. Pricing Analysis
- 16.14.2. Market Share Analysis, 2022
- 16.14.2.1. By Service
- 16.14.2.2. By Type
- 16.14.2.3. By Source
- 16.14.2.4. By Research Area
- 16.14.2.5. By End User
17. Market Structure Analysis
- 17.1. Competition Dashboard
- 17.2. Competition Benchmarking
- 17.3. Market Share Analysis of Top Players
- 17.3.1. By Regional
- 17.3.2. By Service
- 17.3.3. By Type
- 17.3.4. By Source
- 17.3.5. By Research Area
- 17.3.6. By End User
18. Competition Analysis
- 18.1. Competition Deep Dive
- 18.1.1. Thermo Fisher Scientific
- 18.1.1.1. Overview
- 18.1.1.2. Product Portfolio
- 18.1.1.3. Profitability by Market Segments
- 18.1.1.4. Sales Footprint
- 18.1.1.5. Strategy Overview
- 18.1.1.5.1. Marketing Strategy
- 18.1.2. Bio-Rad Laboratories Inc.
- 18.1.2.1. Overview
- 18.1.2.2. Product Portfolio
- 18.1.2.3. Profitability by Market Segments
- 18.1.2.4. Sales Footprint
- 18.1.2.5. Strategy Overview
- 18.1.2.5.1. Marketing Strategy
- 18.1.3. Merck Group
- 18.1.3.1. Overview
- 18.1.3.2. Product Portfolio
- 18.1.3.3. Profitability by Market Segments
- 18.1.3.4. Sales Footprint
- 18.1.3.5. Strategy Overview
- 18.1.3.5.1. Marketing Strategy
- 18.1.4. Cell Signaling Technology, Inc.
- 18.1.4.1. Overview
- 18.1.4.2. Product Portfolio
- 18.1.4.3. Profitability by Market Segments
- 18.1.4.4. Sales Footprint
- 18.1.4.5. Strategy Overview
- 18.1.4.5.1. Marketing Strategy
- 18.1.5. GenScript
- 18.1.5.1. Overview
- 18.1.5.2. Product Portfolio
- 18.1.5.3. Profitability by Market Segments
- 18.1.5.4. Sales Footprint
- 18.1.5.5. Strategy Overview
- 18.1.5.5.1. Marketing Strategy
- 18.1.6. BioLegend
- 18.1.6.1. Overview
- 18.1.6.2. Product Portfolio
- 18.1.6.3. Profitability by Market Segments
- 18.1.6.4. Sales Footprint
- 18.1.6.5. Strategy Overview
- 18.1.6.5.1. Marketing Strategy
- 18.1.7. Abcam Plc
- 18.1.7.1. Overview
- 18.1.7.2. Product Portfolio
- 18.1.7.3. Profitability by Market Segments
- 18.1.7.4. Sales Footprint
- 18.1.7.5. Strategy Overview
- 18.1.7.5.1. Marketing Strategy
- 18.1.8. Agilent Technologies
- 18.1.8.1. Overview
- 18.1.8.2. Product Portfolio
- 18.1.8.3. Profitability by Market Segments
- 18.1.8.4. Sales Footprint
- 18.1.8.5. Strategy Overview
- 18.1.8.5.1. Marketing Strategy
- 18.1.9. Innovagen AB
- 18.1.9.1. Overview
- 18.1.9.2. Product Portfolio
- 18.1.9.3. Profitability by Market Segments
- 18.1.9.4. Sales Footprint
- 18.1.9.5. Strategy Overview
- 18.1.9.5.1. Marketing Strategy
- 18.1.10. Proteogenix
- 18.1.10.1. Overview
- 18.1.10.2. Product Portfolio
- 18.1.10.3. Profitability by Market Segments
- 18.1.10.4. Sales Footprint
- 18.1.10.5. Strategy Overview
- 18.1.10.5.1. Marketing Strategy
- 18.1.11. Bio-Techne
- 18.1.11.1. Overview
- 18.1.11.2. Product Portfolio
- 18.1.11.3. Profitability by Market Segments
- 18.1.11.4. Sales Footprint
- 18.1.11.5. Strategy Overview
- 18.1.11.5.1. Marketing Strategy
- 18.1.12. Creative Diagnostics
- 18.1.12.1. Overview
- 18.1.12.2. Product Portfolio
- 18.1.12.3. Profitability by Market Segments
- 18.1.12.4. Sales Footprint
- 18.1.12.5. Strategy Overview
- 18.1.12.5.1. Marketing Strategy
- 18.1.13. Sino Biological, Inc.
- 18.1.13.1. Overview
- 18.1.13.2. Product Portfolio
- 18.1.13.3. Profitability by Market Segments
- 18.1.13.4. Sales Footprint
- 18.1.13.5. Strategy Overview
- 18.1.13.5.1. Marketing Strategy
- 18.1.14. Raybiotech, Inc.
- 18.1.14.1. Overview
- 18.1.14.2. Product Portfolio
- 18.1.14.3. Profitability by Market Segments
- 18.1.14.4. Sales Footprint
- 18.1.14.5. Strategy Overview
- 18.1.14.5.1. Marketing Strategy
- 18.1.15. ProSci Incorporated
- 18.1.15.1. Overview
- 18.1.15.2. Product Portfolio
- 18.1.15.3. Profitability by Market Segments
- 18.1.15.4. Sales Footprint
- 18.1.15.5. Strategy Overview
- 18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology